IBA Reports Full Year 2022 Results – ALL-TIME RECORD ORDER INTAKE AND BACKLOG

Louvain-la-Neuve, Belgium, 23 March 2023 – IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the 2022 financial year.

(EUR 000)​ FY 2022​ FY 2021​ Variance​ Variance %​
Proton Therapy​ 218 761​ 169 923​ 48 838​ 28.7%​
Other Accelerators​ 88 538​ 90 715​ -2 177​ -2.4%​
Dosimetry​ 53 971​ 52 326​ 1 645​ 3.1%​
 Total Net Sales​ 361 270​ 312 964​ 48 467​ 15.4%​
 REBITDA​ 21 571​ 24 582​ -3 011​ –12.2%​
 % of Sales​ 6.0%​ 7.9%​  ​  ​
 REBIT​ 11 050​ 14 510​ -3 460 -23.8%​
 % of Sales​ 3.1%​ 4.6%​  ​  ​
 Profit Before Tax​ -430​ 8 255​ -8 685​ NA​
 % of Sales​ -0.1%​ 2.6%​  ​  ​
 NET RESULT​ 6 057​ 3 879​ 2 178​ 56.1%​
 % of Sales​ 1.7%​ 1.2%​  ​  ​

Financial summary

  • All-time record annual Equipment order intake of EUR 456 million and Dosimetry order intake of EUR 67 million

  • All-time record overall Equipment and Services backlog of EUR 1.4 billion including Equipment backlog of EUR 713 million an Services backlog of EUR 669 million

  • Total 2022 Group revenues up 15% from 2021 to EUR 361.3 million

  • Proton Therapy and Other Accelerators Services revenue increased 12.8% versus last year to EUR 135 million

  • Gross margin was 1%, compared to 34.4% in 2021

  • Positive 2022 REBIT of EUR 11.1 million, down from EUR 14.5 million in 2021, due to the high inflationary environment, as well as increased investment into R&D, infrastructure, digital technologies and sustainability to maintain IBA’s leading offering and invest in its future growth

  • Total Group net profit of EUR 6.1 million (2021: EUR 3.9 million), positively impacted by deferred tax assets recognition related to improvement of future profitability

  • Strong balance sheet with EUR 158 million gross and EUR 117 million net cash

  • Mid-term guidance announced and dividend of EUR 0.21 per share proposed by the Board, a 10% increase from last year

Read the full Press Release Here:

230323-IBA-FY22-EN

230323-IBA-FY22-results-FR

Press Release